Posts Tagged ‘U.S. F.D.A’

FDA Approves Hepatitis C Treatment Co-Invented by Texas ChE Ph.D. Student

Posted on:
FDA Approves Hepatitis C Treatment Co-Invented by Texas ChE Ph.D. Student

Today the U.S. Food and Drug Administration¬†approved the drug product Zepatier for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients. Texas ChE Ph.D. student Angela Wagner of Professor Nicholas Peppas’ research group¬†was one of the team of eight researchers to co-invent and patent Zepatier.

Hepatitis … Read the rest »